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Expression of urea transporter UT-B confers high urea permeability to mammalian erythrocytes. Erythrocyte membranes also permeate various
urea analogues, suggesting common transport pathways for urea and structurally similar solutes. In this study, we examined UT-B-facilitated
passage of urea analogues and other neutral small solutes by comparing transport properties of wildtype to UT-B-deficient mouse erythrocytes.
Stopped-flow light-scattering measurements indicated high UT-B permeability to urea and chemical analogues formamide, acetamide, methylurea,
methylformamide, ammonium carbamate, and acrylamide, each with PsN5.0×10
−6 cm/s at 10 °C. UT-B genetic knockout and phloretin treatment
of wildtype erythrocytes similarly reduced urea analogue permeabilities. Strong temperature dependencies of formamide, acetamide, acrylamide
and butyramide transport across UT-B-null membranes (EaN10 kcal/mol) suggested efficient diffusion of these amides across lipid bilayers. Urea
analogues dimethylurea, acryalmide, methylurea, thiourea and methylformamide inhibited UT-B-mediated urea transport by N60% in the absence
of transmembrane analogue gradients, supporting a pore-blocking mechanism of UT-B inhibition. Differential transport efficiencies of urea and its
analogues through UT-B provide insight into chemical interactions between neutral solutes and the UT-B pore.
© 2007 Elsevier B.V. All rights reserved.Keywords: Urea; Urea analogue; Erythrocyte; Urea transporter; UT-B1. Introduction
Studies over the past 30 years have demonstrated perme-
ability of mammalian erythrocyte membranes to urea and some
other solutes [1–3]. More recently, seven urea transporter pro-
teins (UT-B and UT-A1-UT-A6) have been cloned from mam-
malian erythrocytes, kidney, and other tissues [4–7]. UT-B
(originally named UT3 and UT11) represents the major urea
transporter in erythrocytes, in addition to being expressed in
kidney descending vasa recta, brain, spleen, ureter, bladder and
testis [8–10].
Humans lacking UT-B (Jk-null blood group) manifest low
urea erythrocyte permeability and slightly impaired urinary
concentrating ability [11,12]. In mice, UT-B knockout by gene
targeting causes defective urea transport across renal vasa recta
and erythrocytes. Impairment of the intrarenal urea-recycling⁎ Corresponding author. Tel.: +1 415 476 8530; fax: +1 415 665 3847.
E-mail address: baoxue.yang@ucsf.edu (B. Yang).
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doi:10.1016/j.bbamem.2007.04.010pathway results in a urea-selective urinary concentrating defect
in these UT-B-null mice [10]. Measurements comparing wild-
type and UT-B-null erythrocyte properties provided evidence for
UT-B as a water but not glycerol transporter [13], and represents
an optimal strategy for defining UT-B selectivity for urea-like
small solutes as well.
The mechanism of small solute transport in erythrocytes has
been a subject of long-standing interest [1,3,14]. It was pre-
viously reported that human erythrocytes are highly permeable
to small non-electrolytes such as formamide and acetamide,
implying the presence of a hydrophilic pathway(s) [15,16].
However, these studies did not establish the molecular route(s)
for urea analogue transport as UTs, other unidentified protein
transporters, or the erythrocyte lipid bilayer membrane [17].
One recent study utilized UT-B-facilitated acetamide transport
as the basis for UT-B small-molecule inhibitor screening [18],
highlighting the utility of defining urea analogue transport
pathways. UT-A urea transporter and aquaglyceroporin are not
meaningfully expressed in mouse erythrocytes (unpublished
1816 D. Zhao et al. / Biochimica et Biophysica Acta 1768 (2007) 1815–1821data). Thus, measurements comparing wildtype and UT-B null
mouse erythrocyte permeation definitively establish relative
solute transport efficiencies through UT-B.
The primary goal of this study was to resolve whether UT-B
widely transports other small non-electrolytes that share similar
structural properties with urea, and to determine quantitatively
transport rates of urea and its analogues through mouse UT-B
and across lipid bilayers. Measuring transmembrane perme-
abilities in wildtype verse UT-B-null erythrocytes, we found
high UT-B transport of formamide, acetamide, methylurea,
methylformamide, ammonium carbamate, acrylamide, glycola-
mide, hydroxyurea, carbahydrazide, but not of butyramide or
isobutyramide. This study also suggests that dimethylurea and
thiourea inhibit UT-B-mediated urea transport by pore blockage
of UT-B rather than by competition with urea.
2. Materials and methods
2.1. Chemicals
All small non-electrolytes studied were obtained from Sigma-Aldrich (St.
Louis, MO). Solutions were freshly made in phosphate-buffered saline (PBS)
prior to experiments.Fig. 1. Erythrocyte solute permeability measured by stopped-flow light scattering. (A)
response to a 250mM inwardly directed gradient of urea analogues. (B)Averaged solute p2.2. Transgenic mice
Transgenic mice in a CD1 background and lacking UT-B were generated by
targeted gene disruption [10]. For permeability measurements, fresh mouse
blood samples obtained in heparinized tubes were washed three times in PBS to
remove serum and the cellular buffy coat and resuspended at ~0.5% hematocrit.
Protocols were approved by the University of California at San Francisco
Committee on Animal Research.
2.3. Erythrocyte urea and small solute permeability measurements
Stopped-flow measurements were carried out on a Hi-Tech Sf-51 instru-
ment. Erythrocyte suspensions were subjected to 250-mM inwardly directed
solute gradients at 10 °C. Experiments were performed at this low temperature
minimize strongly temperature-dependent lipid-mediated solute diffusion. In
some instances, 0.7 mM phloretin was added to erythrocyte suspensions prior to
stopped-flow experiments. The kinetics of changing cell volume was measured
from the time course of 90° light scattering at 530-nm wavelength. Solute
transporter permeability coefficients (Ps) were computed from the relation:
Ps=1/[(S/V)τ], where S/V is surface-to-volume ratio, and τ is the exponential
time constant fitted to the vesicle swelling phase of light scattering
(corresponding to solute entry). To study solute inhibition of urea transport,
erythrocytes were incubated in 200 mM specified solute+PBS for 16 h,
ensuring complete solute equilibration. During subsequent stopped-flow
experiments, erythrocytes were exposed acutely to urea-containing solutions
with maintained solute concentration (500 mM urea+200 mM solute+PBS). InRepresentative curves for the time course of scattered light intensity at 10 °C in
ermeability coefficients (Ps) for experiments done as in panel A (mean±S.E.,n=3).
1817D. Zhao et al. / Biochimica et Biophysica Acta 1768 (2007) 1815–1821some experiments, erythrocytes were incubated with 200 mM solute for only 10
min, and the suspension was washed three times with PBS prior to stopped-flow
experiments.3. Results
3.1. Solute permeabilities of mouse erythrocytes
Solute permeabilities were measured from the time course of
cell swelling in response to a 250-mM inwardly directed soluteFig. 2. Erythrocyte solute permeability mediated by UT-B. (A) Representative curve
wildtype and UT-B-null mice in the absence (top) and presence (bottom) of 0.7 mM ph
(top) and percentage of UT-B mediated Ps in total Ps in erythrocytes (bottom).gradient. An initial rapid decrease in cell volume, reflecting os-
motically induced water efflux, was followed by slower cell
swelling, due to solute and secondary water influx. The data are
presented on two contiguous time scales to clearly demonstrate
both the initial rate of decreasing cell volume and the maximal
signal change after full osmotic equilibration. In Fig. 1A, original
light scattering data shows relative volume changes of wildtype
mouse erythrocytes in response to gradients of 21 representative
solutes. At 10 °C, wildtype erythrocytes were highly permeable
to formamide, urea, acetamide, methylformamide, ammoniums for the time course of scattered light intensity measured in erythrocytes from
loretin at 10 °C. (B) UT-B mediated Ps calculated from Ps
wildtype versus Ps
UT-B-null
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isobutyramide, methylacetamide and glycolamide (Ps of 0.5–
3.5×10−5 cm/s). Erythrocytes exhibited low permeability to hy-
droxyurea, carbohydrazide, dimethylurea, malonamide, hydan-
toin and thiourea (Ps of 0.1–1.7×10
−6 cm/s). Solute permeation
could not be detected for glycine, guanidine, sulfamide,
methanesulfonamide, glycerol, sucrose, mannitol, sorbitol, ade-
nine, alanine, arginine, cysteine, urazole, biuret or uracil (some
data are not shown). Permeability coefficients for the 21
representative solutes are summarized in Fig. 1B.
3.2. UT-B transport of urea analogues
Stopped-flow measurements were made comparing wildtype
and UT-B-null erythrocytes to determine UT-B-facilitated neutral
small solute transport. Fig. 2A shows example curves, which
indicate solute permeability in wildtype and UT-B-null erythro-
cytes with or without UT-B inhibitor phloretin (0.7 mM). Forma-
mide, acetamide and urea permeability was inhibited N80% by
UT-B deletion (Fig. 2A, top) or 0.7 mM phloretin (Fig. 2A,
bottom) in wildtype erythrocytes. Notably, all solutes showedFig. 3. Temperature dependence of solute permeability. (A) Representative curves for
indicated temperatures. (B) Arrhenius plot of ln Ps versus reciprocal absolute temp
analogues derived from panel B.identical permeabilities in UT-B-null erythrocytes both in the
absence and presence of phloretin. UT-B-mediated Ps values,
calculated as the difference between wildtype and UT-B-null
permeabilities, are presented in Fig. 2B (top). UT-B-attributable
Ps for urea, formamide, acetamide, methylurea, methylforma-
mide, ammonium carbamate, and acrylamide ranged from 0.5 to
3.2×10−5. UT-B had lower permeability to glycolamide, hydro-
xyurea, carbohydrazide (Ps of 0.6–1.5×10
−6 cm/s). Phloretin
treatment did not reduce butyramide or isobutyramide perme-
abilities in bothwildtype erythrocytes (Ps of 9.45±0.55 and 6.12±
0.85×10−6 cm/s, respectively) and UT-B-null erythrocytes (Ps
of 9.39±0.37 and 5.84±0.32×10−6 cm/s), demonstrating that
UT-B does not transport butyramide and isobutyramide. In con-
trast, UT-B conferred N70% of total erythrocyte urea, formamide,
acetamide, methylurea, hydroxyurea, and ammonium carbamate
transport (Fig. 2B, bottom).
3.3. Diffusion of amides across the lipid bilayer
Solute permeabilities were measured across UT-B-null ery-
throcytes at three temperatures to establish whether non-UT-B-the time course of scattered light intensity measured in UT-B-null erythrocytes at
erature for experiments done in panel A. (C) Activation energy (Ea) for urea
Fig. 4. Inhibition of urea permeability by urea analogues. (A) Representative curves for the time course of scattered light intensity measured in erythrocytes incubated
with 200 mM of urea analogue for overnight. (B) Averaged solute permeability coefficients (Ps) for experiments done as in panel A (mean±S.E., n=3).
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or by lipid bilayer membrane diffusion. Urea, methylurea, di-
methylurea, hydroxyurea and thiourea permeabilities were low
(b8×10−7 cm/s) at temperatures between 10 °C and 37 °C, and
weakly temperature-dependent (Fig. 3A, some data not shown).
In contrast, formamide, acetamide, acrylamide and butyramide
permeabilities were strongly temperature-dependent, 9-, 11-, 7-
and 7-fold higher, respectively, at 37 °C compared to 10 °C.
Fig. 3B summarizes the data as an Arrhenius plot, whose slope is
proportional to the activation energy, Ea. As tabulated in Fig. 3C,Table 1
Physicochemical properties of solutes (advanced Chemistry Development (ACD/La
Urea Formamide Acetamide Methylur
Volume (A3) 54.196 42.907 59.468 71.87
Log P −2.11 −1.51 −1.234 −0.627
TPSA (A2) 69.1 43.1 43.1 55.121
H-Donor 4 2 2 3
H-Acceptor 3 2 2 3
Charge 0 0 0 0
Glycolamide Hydroxyurea Carbohydrazide Isobutyra
Volume (A3) 67.727 63.32 79.0 92.85
Log P −1.58 −0.94 −3.15 0.166
TPSA (A2) 63.3 75.3 93.171 43.1
H-Donor 3 4 6 2
H-Acceptor 3 4 5 2
Charge 0 0 0 0
Dimethyl-urea Thiourea Guanidine Acetone
Volume (A3) 89.545 63 57.51 64.74
Log P −1.015 −1.05 −1.813 −0.157
TPSA (A2) 41.1 84.1 75.9 17.1
H-Donor 2 4 5 0
H-Acceptor 3 2 3 1
Charge 0 0 0 0Ea exceeded 10 kcal/mol for formamide, acetamide, acrylamide
and butyramide, supporting efficient diffusion through the lipid
bilayer for these solutes.
3.4. Inhibition of UT-B-facilitated urea permeability by urea
analogues
To study the mechanism of analogue inhibition of UT-B-
facilitated urea permeability, wildtype erythrocytes were pre-
equilibrated with 200 mM of urea analogues for overnight. Ureabs) Software V8.14 for Solaris)
ea Methyl-formamide Ammonium Carbamate Acrylamide
60.58 50.925 70.638
−0.598 −1.195 −0.78
29.1 63.3 43.1
1 3 2
2 3 2
0 1 0
mide Butyramide Thioacetamide Methyl-acetamide
93.07 68.37 77.143
0.482 −0.26 −1.05
43.1 58.1 29.1
2 2 1
2 1 2
0 0 0
Glycine Hydantoin Urazole
67.727 81.36 76.96
−2.55 −1.690 −1.68
63.322 58.2 70.2
3 2 3
3 4 5
0 0 0
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of an external solution containing 200 mM analogue and satu-
rating (500 mM) urea, with representative curves presented in
Fig. 4A. Urea flux was inhibited 98% by dimethylurea, 93% by
acrylamide, 87% by methylurea, 72% by thiourea and 64% by
methylformamide. Under these conditions, butyramide, acryl-
amide, acetamide, formamide and urea did not appreciably
inhibit urea permeability in erythrocytes (Fig. 4B). To define if
the inhibitory action of urea analogues is reversible, 200 mM of
dimethyl urea, acrylamide, methylurea, thiourea or methylfor-
mamide was incubated with erythrocytes and the erythrocyte
suspension was washed 3 times with PBS prior to stopped-flow
experiments. Inhibition of UT-B by all these solutes was absent
after washes (data not shown).
4. Discussion
This study defines transport efficiencies of mouse UT-B to
urea analogues and other neutral small solutes. Urea is a polar,
highly water soluble, and charge neutral molecule, with an
oxygen and two nitrogen atoms serving as hydrogen bond
acceptors, and two amino functions providing a total of four
hydrogen bonds for donation. High polarity and water solubility
necessitates a polar-hydrophilic pathway(s) for efficient trans-
membrane urea transport. To establish that UT-B indeed serves
as this hydrophilic conduit, we selected close analogues of urea
with varied physicochemical properties such as molecular size,
lipophillicity (log P), polar surface area (TPSA) and hydrogen
bonding capacities (Table 1) and studied their UT-B transport
characteristics. Comparative permeability measurements made
on wildtype versus UT-B-null mouse erythrocytes showed sub-
stantial UT-B-facilitated transport of formamide, acetamide,
methylurea, methylformamide, ammonium carbamate and acry-
lamide. Transport of the amides formamide, acetamide, meth-
ylformamide, acrylamide, butyramide and isobutyramide was
strongly temperature dependent, indicative of diffusion across
the erythrocyte lipid bilayer.
UT-B-mediated transport requires at least one primary amide
i.e. carbonyl function attached to a primary unsubstituted amino
group. Indeed, UT-B mediates efficient transport of formamide,
acetamide, carbamate, and acrylamide, all of which contain
primary amide functions. N-methlyated amides are poorly
transported by UT-B, as evidenced by the relative 3- and 15-fold
slowed transmembrane flux of methylurea and dimethylurea,
respectively. Methylation decreases amide hydrogen bond
capacity increases lipophilicity and molecular size. Compounds
lacking amide functionalities altogether, such as glycine and
acetic acid, are not transported by UT-B.
Acetamide and urea have similar molecular sizes, with both
also possessing an oxygen to accept hydrogen bonding. Re-
placement of this oxygen by sulfur, as in thioacetamide and
thiourea, results in reduced UT-B-facilitated transport. This
could be attributed to loss of hydrogen bonding capacity of
sulfur. In addition, molecular volumes and polar surface areas
are greater in sulfur-containing compounds compared to their
oxygen-containing counterparts (Table 1). Similarly, guanidine
with comparable physicochemical properties as that of urea,was not transported by UT-B, as it replaces urea carbonyl by
imine function (C_N–H). More lipophilic, less polar analo-
gues such as butyramide, isobutyramide, and acetone tend to
rely upon membrane diffusion rather than UT-B facilitated
transport.
In hydrophilic transport pathways, hydrogen bond formation
is one of the essential processes conferring transport specificity.
Using X-ray crystallographic studies and mathematical simula-
tions it has been demonstrated that the polar-neutral molecules
like water [19,20] and glycerol [21,22] are transported by
forming hydrogen bonds with the inner surfaces of aquaporin
and aquaglyceroporin GlpF channels, respectively. Urea is also
a highly polar molecule with significant hydrogen bonding
capacity, and it seems likely that UT-B-facilitated transport
relies on hydrogen bonding.
Taken together, UT-B prefers to transport neutral, more
hydrophilic, urea and primary amides that have more H-
bonding capacity and selectively retard transport of lipophilic
molecules. Large analogues with less hydrogen bonding
capacity tend to have less permeability. This suggests that
UT-B provides a unique type of narrow hydrophilic pathway for
transportation of urea and transport specificity/selectivity may
largely be govern by H-bonding capacity, size, and hydrophilic
nature of solute.
Since urea analogues such as thiourea and acetamide are
similar to urea in structure, they were suggested to inhibit urea
transport by interacting competitively at transport sites [23,24].
In 1974,Wieth et al. demonstrated competition between thiourea
and urea [25]. Chou and Knepper [23] reported 74% inhibition
of Ps by 200 mM thiourea in inner medullary collecting duct (as
well as 65% inhibition by methylurea and a 35% inhibition by
acetamide), where UT-A isoforms are expressed. Smith et al.
reported that urea derivatives could inhibit UT-B [26]. It has
been proposed that thiourea inhibits urea transport through
human UT-B (UT-11) competitively [27]. In the present study,
200 mM dimethylurea, acrylamide, methylurea, thiourea and
methylformamide, but not acetamide and formamide, strongly
inhibited urea flux through UT-B in the absence of a trans-
membrane analogue gradient. The results suggest that the afore-
mentioned active inhibitors decrease urea permeability mainly
by high-affinity UT-B blockage. Indeed, the 10-fold greater
erythrocyte binding affinity of thiourea compared to urea sug-
gests a pore-blocking mechanism of inhibition [3].
In summary, the studies here establish erythrocyte UT-B as
an efficient transporter of formamide, acetamide, methylurea,
methylformamide, ammonium carbamate, acrylamide, glycola-
mide, hydroxyurea, and carbahydrazide. The larger lipophilic
amide analogues butyramide and isobutyramide, only diffuse
through the lipid bilayer. Urea analogues dimethylurea, acry-
lamide, methylurea, thiourea and methylformamide were found
to decrease urea permeability predominantly by blockage of
UT-B rather than competitive interaction. This study thus pro-
vides basic information regarding UT-B solutes binding re-
quirements and characteristics. Until high-resolution crystal
structures of UTs are elucidated, this new information combined
with computational modeling should prove useful in rational
drug development of channel inhibitors and activators.
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